Palvella Therapeutics (PVLA) Return on Assets Growth (1y) (2015 - 2026)

Palvella Therapeutics (PVLA) Return on Assets Growth (1y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn -
2 Nanobiotix 1,935.05 Bn 1,934.98 Bn -
3 Akari Therapeutics 1,021.31 Bn 1,021.31 Bn -
4 BeOne Medicines 467.89 Bn 463.10 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.95 Bn 115.70 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.19 Bn 61.44 Bn 3.31 Bn
7 Belite Bio 63.46 Bn 63.46 Bn -
8 Argenx Se 55.64 Bn 50.45 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.67 Bn 34.66 Bn 959.66 Mn
10 Palvella Therapeutics 1.86 Bn 1.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 -1.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 1.00
Jun 30, 2024 0.00
Mar 31, 2024 1.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00